Geode Capital Management’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-624,146
| Closed | -$3.22M | – | 4303 |
|
|
2019
Q2 | $3.22M | Buy |
624,146
+52,062
| +9% | +$269K | ﹤0.01% | 2648 |
|
|
2019
Q1 | $2.06M | Buy |
572,084
+45,755
| +9% | +$165K | ﹤0.01% | 2828 |
|
|
2018
Q4 | $3.23M | Buy |
526,329
+91,968
| +21% | +$564K | ﹤0.01% | 2492 |
|
|
2018
Q3 | $2.54M | Buy |
434,361
+31,312
| +8% | +$183K | ﹤0.01% | 2758 |
|
|
2018
Q2 | $1.71M | Buy |
403,049
+86,114
| +27% | +$366K | ﹤0.01% | 2942 |
|
|
2018
Q1 | $1.4M | Buy |
316,935
+3,309
| +1% | +$14.6K | ﹤0.01% | 2960 |
|
|
2017
Q4 | $1.65M | Buy |
313,626
+21,654
| +7% | +$114K | ﹤0.01% | 2862 |
|
|
2017
Q3 | $1.79M | Buy |
291,972
+5,373
| +2% | +$32.9K | ﹤0.01% | 2818 |
|
|
2017
Q2 | $2.07M | Buy |
286,599
+43,247
| +18% | +$313K | ﹤0.01% | 2712 |
|
|
2017
Q1 | $1.29M | Buy |
243,352
+10,465
| +4% | +$55.4K | ﹤0.01% | 2894 |
|
|
2016
Q4 | $1.67M | Buy |
232,887
+26,332
| +13% | +$189K | ﹤0.01% | 2726 |
|
|
2016
Q3 | $1.93M | Buy |
206,555
+17,370
| +9% | +$163K | ﹤0.01% | 2579 |
|
|
2016
Q2 | $1.2M | Buy |
189,185
+5,304
| +3% | +$33.5K | ﹤0.01% | 2804 |
|
|
2016
Q1 | $1.02K | Buy |
183,881
+2,550
| +1% | +$14 | ﹤0.01% | 2872 |
|
|
2015
Q4 | $1.01M | Buy |
181,331
+1,551
| +0.9% | +$8.65K | ﹤0.01% | 2909 |
|
|
2015
Q3 | $1.52M | Buy |
179,780
+4,063
| +2% | +$34.4K | ﹤0.01% | 2617 |
|
|
2015
Q2 | $2.66M | Buy |
175,717
+997
| +0.6% | +$15.1K | ﹤0.01% | 2317 |
|
|
2015
Q1 | $2.8M | Buy |
174,720
+2,697
| +2% | +$43.2K | ﹤0.01% | 2225 |
|
|
2014
Q4 | $3.07M | Buy |
172,023
+49,210
| +40% | +$877K | ﹤0.01% | 2132 |
|
|
2014
Q3 | $1.23M | Buy |
122,813
+15,961
| +15% | +$160K | ﹤0.01% | 2662 |
|
|
2014
Q2 | $1.67M | Buy |
106,852
+12,436
| +13% | +$194K | ﹤0.01% | 2490 |
|
|
2014
Q1 | $1.75M | Buy |
94,416
+60,226
| +176% | +$1.12M | ﹤0.01% | 2415 |
|
|
2013
Q4 | $653K | Buy |
34,190
+732
| +2% | +$14K | ﹤0.01% | 2950 |
|
|
2013
Q3 | $547K | Buy |
+33,458
| New | +$547K | ﹤0.01% | 2903 |
|